# Naloxone Nasal Spray Compared With Naloxone Injection for Opioid Overdoses Outside the Hospital

> **NCT03518021** · PHASE3 · COMPLETED · sponsor: **Norwegian University of Science and Technology** · enrollment: 286 (actual)

## Conditions studied

- Overdose
- Drug Abuse

## Interventions

- **DRUG:** Naloxone, intranasal
- **DRUG:** placebo, intranasal
- **DRUG:** Naloxone, intramuscular
- **DRUG:** placebo, intramuscular

## Key facts

- **NCT ID:** NCT03518021
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-15
- **Primary completion:** 2020-10-06
- **Final completion:** 2020-10-06
- **Target enrollment:** 286 (ACTUAL)
- **Last updated:** 2020-10-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03518021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03518021, "Naloxone Nasal Spray Compared With Naloxone Injection for Opioid Overdoses Outside the Hospital". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT03518021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*